Dandekar Atul
SEC insider (Form 3/4/5 filer). CIK 0002050167. CSBO at Maze Therapeutics, Inc. (MAZE). 36 reported Form 4/5 transactions since Sep 2024; latest on Sep 29, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Dandekar Atul has filed insider reports for
- Maze Therapeutics, Inc. (MAZE): Officer, CSBO
Dandekar Atul
CIK: 0002050167
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Maze Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (36 total)
- Sep 29, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect7.5K shares at avg. $27.06$203K - Sep 29, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $10.42$78K - Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect3.2K shares at avg. $26.01$83K - Sep 3, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect36 shares at avg. $25.81$929.16 - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect2.8K shares at avg. $26.38$74K - Sep 2, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect391 shares at avg. $27.12$11K - Sep 1, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect12.5K shares- - Jul 29, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect400 shares at avg. $27.89$11K - Jul 29, 2026MAZE
Maze Therapeutics, Inc.
SaleDirect7.1K shares at avg. $27.31$194K - Jul 29, 2026MAZE
Maze Therapeutics, Inc.
ExerciseDirect7.5K shares at avg. $10.42$78K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 29, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 7,500 | $27.06 | $202,921 | Direct |
| Sep 29, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 7,500 | $10.42 | $78,150 | Direct |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 3,207 | $26.01 | $83,425 | Direct |
| Sep 3, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 36 | $25.81 | $929 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 2,800 | $26.38 | $73,853 | Direct |
| Sep 2, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 391 | $27.12 | $10,604 | Direct |
| Sep 1, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 12,500 | - | $0 | Direct |
| Jul 29, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 400 | $27.89 | $11,156 | Direct |
| Jul 29, 2026 | MAZE Maze Therapeutics, Inc. | Sale | 7,100 | $27.31 | $193,875 | Direct |
| Jul 29, 2026 | MAZE Maze Therapeutics, Inc. | Exercise | 7,500 | $10.42 | $78,150 | Direct |
1-10 of 36 transactions